Raloxifene [orch, phsu]
Impedance [phsf]
Flow [npop]
Uterine Artery [bpoc]
postmenopausal [tmco]
Women [popg]
randomized [resa]
placebo-controlled [resa]
Comparative Study [inpr]
Objective [inpr]
investigate [ftcn]
Long-Term Effect [phpr]
Raloxifene [orch, phsu]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
Impedance [phsf]
Flow [npop]
Uterine Artery [bpoc]
postmenopausal [tmco]
Women [popg]
Study Design [resa]
prospective [resa]
randomized [resa]
DOUBLE BLIND [resa]
placebo controlled study [inpr, resa]
Performed [ftcn]
postmenopausal [tmco]
Women [popg]
Received [qlco]
mg% [qnco]
Raloxifene [orch, phsu]
Daily [tmco]
Raloxifene [orch, phsu]
Group [idcn]
mg% [qnco]
Raloxifene [orch, phsu]
Daily [tmco]
Raloxifene [orch, phsu]
Group [idcn]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
placebo [topp]
baseline [bodm]
months [tmco]
Ultrasonography, Doppler, Color [diap]
Measure [qnco]
Pulsatility index [clna]
Uterine Artery [bpoc]
months [tmco]
treatment [ftcn]
Compared [acty]
placebo [topp]
decreases [qnco]
PI [clna]
Raloxifene [orch, phsu]
Group [idcn]
P NOS [aapp, imft]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
Group [idcn]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
Group [idcn]
Compared [acty]
placebo [topp]
Group [idcn]
months [tmco]
decreases [qnco]
Observed [ftcn]
Pulsatility index [clna]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
Group [idcn]
Decrease [qlco]
mg% [qnco]
Raloxifene [orch, phsu]
Daily [tmco]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
Impedance [phsf]
Flow [npop]
Uterine Artery [bpoc]
High dose [qnco]
Raloxifene [orch, phsu]
exert [orgf]
CARDIOVASCULAR [bdsy]
Protection [fndg]
